A minimal complex of KHNYN and zinc-finger antiviral protein binds and degrades single-stranded RNA
Edited by Wesley Sundquist, University of Utah Hospital, Salt Lake City, UT; received July 27, 2024; accepted November 18, 2024
Significance
In cells, ZAP (zinc-finger antiviral protein) and KHNYN (KH-like and NYN domain containing protein) act together with partners to recognize and deplete viral RNA containing CpG dinucleotide clusters. Using purified recombinant proteins and biochemical assays, we define a minimal ZAP:KHNYN complex that degrades single-stranded RNA and propose a model for how this core would interact with viral RNA that contains CpG clusters.
Abstract
Detecting viral infection is a key role of the innate immune system. The genomes of some RNA viruses have a high CpG dinucleotide content relative to most vertebrate cell RNAs, making CpGs a molecular marker of infection. The human zinc-finger antiviral protein (ZAP) recognizes CpG, mediates clearance of the foreign CpG-rich RNA, and causes attenuation of CpG-rich RNA viruses. While ZAP binds RNA, it lacks enzymatic activity that might be responsible for RNA degradation and thus requires interacting cofactors for its function. One of these cofactors, KHNYN, has a predicted nuclease domain. Using biochemical approaches, we found that the KHNYN NYN domain is a single-stranded RNA ribonuclease that does not have sequence specificity and digests RNA with or without CpG dinucleotides equivalently in vitro. We show that unlike most KH domains, the KHNYN KH domain does not bind RNA. Indeed, a crystal structure of the KH region revealed a double-KH domain with a negatively charged surface that accounts for the lack of RNA binding. Rather, the KHNYN C-terminal domain (CTD) interacts with the ZAP RNA-binding domain (RBD) to provide target RNA specificity. We define a minimal complex composed of the ZAP RBD and the KHNYN NYN-CTD and use a fluorescence polarization assay to propose a model for how this complex interacts with a CpG dinucleotide-containing RNA. In the context of the cell, this module would represent the minimum ZAP and KHNYN domains required for CpG-recognition and ribonuclease activity essential for attenuation of viruses with clusters of CpG dinucleotides.
Get full access to this article
Purchase, subscribe or recommend this article to your librarian.
Data, Materials, and Software Availability
Crystal structure data have been deposited in Protein Data Base (9CS9) (46). All study data are included in the article and/or SI Appendix.
Note Added in Proof.
A recently published crystal structure of KHNYN NYN [PBD 8WZC (47)] agrees with the KHNYN NYN AlphaFold2 model with an RMSD of 0.49 Å for 155 Ca atoms (Fig. 6).
Acknowledgments
We thank Jennifer Bohn (Rockefeller University) and members of the M.D.O. and J.L.S. labs for helpful advice. Madeline Shay and Emily Ellinger (University of Michigan) assisted with purification of a recombinant protein. This work was supported by the Center for HIV RNA studies (NIH U54 AI170660 to P.D.B., M.D.O., and J.L.S.). Z.C.Y. was supported by NIH T32 GM132046. Use of GM/CA in Sector 23 at the Advanced Photon Source (APS) has been funded by the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006, P30GM138396). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.
Author contributions
Z.C.Y., J.L.M., P.D.B., J.L.S., and M.D.O. designed research; Z.C.Y., J.L.M., and C.-Y.K. performed research; Z.C.Y., J.L.M., C.-Y.K., J.L.S., and M.D.O. analyzed data; and Z.C.Y., J.L.M., P.D.B., J.L.S., and M.D.O. wrote the paper.
Competing interests
The authors declare no competing interest.
Supporting Information
Appendix 01 (PDF)
- Download
- 1.74 MB
References
1
B. D. Greenbaum, A. J. Levine, G. Bhanot, R. Rabadan, Patterns of evolution and host gene mimicry in influenza and other RNA viruses. PLOS Pathog. 4, e1000079 (2008).
2
M. A. Takata et al., CG dinucleotide suppression enables antiviral defence targeting non-self RNA. Nature 550, 124–127 (2017).
3
G. Gao, X. Guo, S. P. Goff, Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 297, 1703–1706 (2002).
4
X. Guo, J.-W.N. Carroll, M. R. MacDonald, S. P. Goff, G. Gao, The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs. J. Virol. 78, 12781–12787 (2004).
5
M. J. Bick et al., Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J. Virol. 77, 11555–11562 (2003).
6
S. Müller et al., Inhibition of filovirus replication by the zinc finger antiviral protein. J. Virol. 81, 2391–2400 (2007).
7
M. M. H. Li et al., Characterization of novel splice variants of zinc finger antiviral protein (ZAP). J. Virol. 93, e00715-19 (2019).
8
J. L. Meagher et al., Structure of the zinc-finger antiviral protein in complex with RNA reveals a mechanism for selective targeting of CG-rich viral sequences. Proc. Natl. Acad. Sci. U.S.A. 116, 24303–24309 (2019).
9
X. Luo et al., Molecular mechanism of RNA recognition by zinc-finger antiviral protein. Cell Rep. 30, 46–52.e4 (2020).
10
G. Xue et al., Poly(ADP-ribose) potentiates ZAP antiviral activity. PLOS Pathog. 18, e1009202 (2022).
11
T. Karlberg et al., Structural basis for lack of ADP-ribosyltransferase activity in poly(ADP-ribose) polymerase-13/zinc finger antiviral protein. J. Biol. Chem. 290, 7336–7344 (2015).
12
J. A. Bohn et al., Functional anatomy of the zinc finger antiviral protein complex. Nat. Commun., in press.
13
D. Gonçalves-Carneiro et al., Rational attenuation of RNA viruses with zinc finger antiviral protein. Nat. Microbiol. 7, 1558–1567 (2022).
14
M. Ficarelli et al., KHNYN is essential for the zinc finger antiviral protein (ZAP) to restrict HIV-1 containing clustered CpG dinucleotides. eLife 8, e46767 (2019).
15
V. Anantharaman, L. Aravind, The NYN domains: Novel predicted RNAses with a PIN domain-like fold. RNA Biol. 3, 18–27 (2006).
16
N. V. Grishin, KH domain: One motif, two folds. Nucleic Acids Res. 29, 638–643 (2001).
17
E. Santonico, New Insights into the Mechanisms Underlying NEDD8 Structural and Functional Specificities (IntechOpen, 2019).
18
G. Nicastro, I. A. Taylor, A. Ramos, KH-RNA interactions: Back in the groove. Curr. Opin. Struct. Biol. 30, 63–70 (2015).
19
L. Castagnoli et al., Selectivity of the CUBAN domain in the recognition of ubiquitin and NEDD8. FEBS J. 286, 653–677 (2019).
20
X. Zheng et al., TRIM25 is required for the antiviral activity of zinc finger antiviral protein. J. Virol. 91, e00088-17 (2017).
21
M. M. H. Li et al., TRIM25 enhances the antiviral action of zinc-finger antiviral protein (ZAP). PLoS Pathog. 13, e1006145 (2017).
22
J. G. Sanchez et al., TRIM25 binds RNA to modulate cellular anti-viral defense. J. Mol. Biol. 430, 5280–5293 (2018).
23
M. V. Buckmaster, S. P. Goff, Riplet binds the zinc finger antiviral protein (ZAP) and augments ZAP-mediated restriction of HIV-1. J. Virol. 96, e0052622 (2022).
24
R. Valverde, L. Edwards, L. Regan, Structure and function of KH domains. FEBS J. 275, 2712–2726 (2008).
25
L. Yang et al., The human RNA-binding protein and E3 ligase MEX-3C binds the MEX-3-recognition element (MRE) motif with high affinity. J. Biol. Chem. 292, 16221–16234 (2017).
26
Z. Du, S. Fenn, R. Tjhen, T. L. James, Structure of a construct of a human poly(C)-binding protein containing the first and second KH domains reveals insights into its regulatory mechanisms. J. Biol. Chem. 283, 28757–28766 (2008).
27
H. A. Lewis et al., Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains. Struct. Lond. Engl. 1993, 191–203 (1999).
28
Z. Du et al., X-ray crystallographic and NMR studies of protein–protein and protein–nucleic acid interactions involving the KH domains from human poly(C)-binding protein-2. RNA 13, 1043–1051 (2007).
29
D. Kmiec, M. J. Lista, M. Ficarelli, C. M. Swanson, S. J. D. Neil, S-farnesylation is essential for antiviral activity of the long ZAP isoform against RNA viruses with diverse replication strategies. PLOS Pathog. 17, e1009726 (2021).
30
R. P. Galão et al., TRIM25 and ZAP target the Ebola virus ribonucleoprotein complex to mediate interferon-induced restriction. PLOS Pathog. 18, e1010530 (2022).
31
E. Yang, L. P. Nguyen, C. A. Wisherop, R. L. Kan, M. M. H. Li, The role of ZAP and TRIM25 RNA binding in restricting viral translation. Front. Cell. Infect. Microbiol. 12, 886929 (2022).
32
D. Gonçalves-Carneiro, M. A. Takata, H. Ong, A. Shilton, P. D. Bieniasz, Origin and evolution of the zinc finger antiviral protein. PLoS Pathog. 17, e1009545 (2021).
33
J. G. Sanchez et al., The tripartite motif coiled-coil is an elongated antiparallel hairpin dimer. Proc. Natl. Acad. Sci. U.S.A. 111, 2494–2499 (2014).
34
D. M. Dawidziak, J. G. Sanchez, J. M. Wagner, B. K. Ganser-Pornillos, O. Pornillos, Structure and catalytic activation of the TRIM23 RING E3 ubiquitin ligase. Proteins 85, 1957–1961 (2017).
35
M. G. Koliopoulos, D. Esposito, E. Christodoulou, I. A. Taylor, K. Rittinger, Functional role of TRIM E3 ligase oligomerization and regulation of catalytic activity. EMBO J. 35, 1204–1218 (2016).
36
L. Stols et al., A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site. Protein Expr. Purif. 25, 8–15 (2002).
37
J. DelProposto, C. Y. Majmudar, J. L. Smith, W. C. Brown, Mocr: A novel fusion tag for enhancing solubility that is compatible with structural biology applications. Protein Expr. Purif. 63, 40–49 (2009).
38
C. A. Schneider, W. S. Rasband, K. W. Eliceiri, NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).
39
W. Kabsch, XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132 (2010).
40
A. J. McCoy et al., Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).
41
P. D. Adams et al., PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
42
P. Emsley, B. Lohkamp, W. G. Scott, K. Cowtan, Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
43
V. B. Chen et al., MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12–21 (2010).
44
J. Jumper et al., Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
45
T. D. Goddard et al., UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. Publ. Protein Soc. 27, 14–25 (2018).
46
Z. C. Yeoh, M. D. Ohi, J. L. Smith, 9CS9: KHNYN KH1-KH2. Protein Data Bank. https://doi.org/10.2210/pdb9cs9/pdb. Deposited 22 August 2024.
47
S. Hong, J. Choe, Crystal Structure of NYN domain of Human KHNYN in complex with single strand RNA. Biochem. Biophys. Res. Commun. 736, e150545 (2024).
Information & Authors
Information
Published in
Classifications
Copyright
Copyright © 2024 the Author(s). Published by PNAS. This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).
Data, Materials, and Software Availability
Crystal structure data have been deposited in Protein Data Base (9CS9) (46). All study data are included in the article and/or SI Appendix.
A recently published crystal structure of KHNYN NYN [PBD 8WZC (47)] agrees with the KHNYN NYN AlphaFold2 model with an RMSD of 0.49 Å for 155 Ca atoms (Fig. 6).
Submission history
Received: July 27, 2024
Accepted: November 18, 2024
Published online: December 18, 2024
Published in issue: December 24, 2024
Keywords
Acknowledgments
We thank Jennifer Bohn (Rockefeller University) and members of the M.D.O. and J.L.S. labs for helpful advice. Madeline Shay and Emily Ellinger (University of Michigan) assisted with purification of a recombinant protein. This work was supported by the Center for HIV RNA studies (NIH U54 AI170660 to P.D.B., M.D.O., and J.L.S.). Z.C.Y. was supported by NIH T32 GM132046. Use of GM/CA in Sector 23 at the Advanced Photon Source (APS) has been funded by the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006, P30GM138396). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.
Author contributions
Z.C.Y., J.L.M., P.D.B., J.L.S., and M.D.O. designed research; Z.C.Y., J.L.M., and C.-Y.K. performed research; Z.C.Y., J.L.M., C.-Y.K., J.L.S., and M.D.O. analyzed data; and Z.C.Y., J.L.M., P.D.B., J.L.S., and M.D.O. wrote the paper.
Competing interests
The authors declare no competing interest.
Notes
This article is a PNAS Direct Submission.
Authors
Metrics & Citations
Metrics
Altmetrics
Citations
Cite this article
A minimal complex of KHNYN and zinc-finger antiviral protein binds and degrades single-stranded RNA, Proc. Natl. Acad. Sci. U.S.A.
121 (52) e2415048121,
https://doi.org/10.1073/pnas.2415048121
(2024).
Copied!
Copying failed.
Export the article citation data by selecting a format from the list below and clicking Export.
Cited by
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginRecommend to a librarian
Recommend PNAS to a LibrarianPurchase options
Purchase this article to access the full text.
Restore content access
View options
PDF format
Download this article as a PDF file
DOWNLOAD PDF